Drugs / NuQu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01771471 | Nov 2012 → Sep 2020 | lumbar disk degenerative disorder | ISTO Technologies, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NuQu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01771471 ↗ |
| Modality | Cell therapy | “Allogenic juvenile chondrocytes (NuQu) in fibrin carrier.” NCT01771471 ↗ |
| Route | Other | “juvenile chondrocytes, delivered in fibrin carrier (NuQu®) to the nucleus of lumbar intervertebral discs” NCT01771471 ↗ |